版权说明 操作指南
首页 > 成果 > 详情

Combined effect of recombinant human adenovirus p53 and curcumin in the treatment of liver cancer

认领
导出
Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Qu, Juan;Lu, Wei;Chen, Ming;Gao, Wei;Zhang, Cong;...
通讯作者:
Yang, Jizhi
作者机构:
[Qu, Juan] Tianjin Nankai Hosp, Dept Gastroenterol, Tianjin 300100, Peoples R China.
[Lu, Wei] Tianjin Canc Hosp, Dept Gastroenterol, Tianjin 300060, Peoples R China.
[Chen, Ming; Zhang, Cong; Gao, Wei] Tianjin Nankai Hosp, Dept Hepatopathy & Hepat Oncol, Tianjin 300100, Peoples R China.
[Guo, Bin] Hunan Univ Chinese Med, Coll Acumoxibust & Massage, Changsha 410208, Hunan, Peoples R China.
[Yang, Jizhi] Chentangzhuang St Hlth Serv Ctr, Dept Tradit Chinese Med, 29 Little Haiti Maoming Rd, Tianjin 300222, Peoples R China.
通讯机构:
[Yang, Jizhi] C
Chentangzhuang St Hlth Serv Ctr, Dept Tradit Chinese Med, 29 Little Haiti Maoming Rd, Tianjin 300222, Peoples R China.
语种:
英文
关键词:
TP53;curcumin;hepatocellular carcinoma;mitogen activated protein kinase;rAd-p53
期刊:
Experimental and Therapeutic Medicine
ISSN:
1792-0981
年:
2020
卷:
20
期:
5
页码:
18
机构署名:
本校为其他机构
院系归属:
针灸推拿与康复学院
摘要:
The development of an effective therapeutic intervention for liver cancer is a worldwide challenge that remains to be adequately addressed. Of note, TP53, which encodes the p53 protein, is an important tumor suppressor gene, 61% of TP53 is functionally inactivated in liver cancer. Recombinant human adenovirus p53 (rAd-p53) is the first commercial product that has been used for gene therapy. In the present study, the combined mechanistic effects of rAd-p53 and curcumin, a naturally occurring compound with previously reported anti-inflammatory, antioxidant and anti-cancer properties, were assess...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com